CRISPR Therapeutics vs Tessera Therapeutics

CRISPR Therapeutics develops gene-editing medicines built on CRISPR/Cas9, including the approved cell therapy Casgevy and the investigational in vivo liver therapy CTX310, for patients with serious and cardiometabolic diseases.

Biotech

Tessera Therapeutics

Gene Writing platform using engineered mobile genetic elements to write everything from single bases to whole genes.

Enter email for free access.

Free. By continuing you'll get The Briefing every morning — one click to unsubscribe. Terms · Privacy

Access includes:

The Audio Brief: everything you need to know about frontier tech in under 10 minutes a day.

30 sectors
One dashboard each, refreshed every day.
1,200+ companies
Funding, leadership, hiring, competitors.
Jobs board
Roles at companies LinkedIn never shows.
Frontier TV
A thousand-video wall from official channels.
Investors & exits
Who funds the frontier, and who bought what.
Frontline
The day's developments in every sector, scored.